Call Us: +1 (800) 722-4123 
31
Years in
Business
As of September 30, 2024
Read Emerald’s latest white paper “Innovation Driven Investment Opportunities in Life Sciences”
Learn More
Co-Directors of Life Sciences Research
Stocks are trending down early this morning as China announced an investigation into Nvidia exploring the possibility of monopolistic practices in the purchase of an Israeli tech firm (even though it was approved by Bejing, four years ago).
Simply put, Emerald manages investment portfolios for our clients. What separates us from other asset management firms is our team and the proprietary research and investment management process.
Learn More
David Volpe, CFA and deputy CIO of Emerald Asset Management, talks about NVIDIA’s Q3 earnings and how they exceeded expectations.
